0001140361-15-008408.txt : 20150223 0001140361-15-008408.hdr.sgml : 20150221 20150223155630 ACCESSION NUMBER: 0001140361-15-008408 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150223 DATE AS OF CHANGE: 20150223 EFFECTIVENESS DATE: 20150223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SELEXYS PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001442824 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-184899 FILM NUMBER: 15639644 BUSINESS ADDRESS: STREET 1: 800 RESEARCH PARKWAY STREET 2: SUITE 334 CITY: OKLAHOMA CITY STATE: OK ZIP: 73104 BUSINESS PHONE: 405-319-8198 MAIL ADDRESS: STREET 1: 800 RESEARCH PARKWAY STREET 2: SUITE 334 CITY: OKLAHOMA CITY STATE: OK ZIP: 73104 D/A 1 primary_doc.xml X0707 D/A LIVE 0001442824 SELEXYS PHARMACEUTICALS CORP 840 RESEARCH PARKWAY SUITE 516 OKLAHOMA CITY OK OKLAHOMA 73104 405-319-8198 DELAWARE None None Corporation true Scott Rollins, Ph.D. 5501 White Fences Oklahoma City OK OKLAHOMA 73131 Executive Officer Director Rodger McEver, M.D. 1716 Guilford Lane Oklahoma City OK OKLAHOMA 73120 Director Richard Alvarez 3604 Katherine Court Edmond OK OKLAHOMA 73013 Executive Officer David Falconer 1707 Winding Ridge Rd Edmond OK OKLAHOMA 73034 Executive Officer Philip Jones, M.D. 801 Hawkesbury Park Norman OK OKLAHOMA 73072 Director Russell Rother 10325 Forest Meadow Dr Oklahoma City OK OKLAHOMA 73151 Executive Officer David Keiser 408 Boston Post Rd. Madison CT CONNECTICUT 06443 Director Todd Foley The John Hancock Tower 200 Clarendon Street, 54th Floor Boston MA MASSACHUSETTS 02116 Director Biotechnology No Revenues 06b true 0001140361-12-042306 2012-09-17 true true true false 13217 43196831 43196831 0 Includes warrant issued for $10,000,000, $24,459,532 of Series A Preferred Shares at the initial closing ($10,659,534 of which was from the conversion of outstanding notes), and $8,737,299 of Series A Preferred Shares at the second closing. false 57 0 0 4864000 true Estimated amount includes officers' salaries and bonuses paid since the initial filing and estimated salaries and potential bonuses for the period over which the proceeds of the offering are expected to be expended. false SELEXYS PHARMACEUTICALS CORP Douglas A. Branch Douglas A. Branch Secretary 2015-02-23